According to a new report by Polaris Market Research, the global Smart Pills market was valued at USD 1.0 billion in 2025 and is projected to reach USD 4.1 billion by 2034, expanding at a CAGR of 18.90% over the forecast period. Growth is underpinned by rising digital-health innovation, expanding diagnostics via ingestible sensors, and increasing demand for minimally invasive procedures across key end-use industries.
What Is Driving Smart Pills Market Growth?
Demand is climbing as growing prevalence of gastrointestinal disorders converges with heightened patient preference for non-invasive diagnostics, pushing smart pill adoption across hospitals and diagnostic centers. Manufacturers are prioritizing AI-enabled sensor design and remote monitoring capability, expanding smart pill adoption across North America, Asia Pacific, and Europe. Polaris analysts note that the aging population and rising chronic-disease burden position the capsule endoscopy segment for sustained double-digit growth through 2034, with hospitals emerging as the fastest-growing end-use contributor and Asia Pacific posting the fastest incremental gains.
Key Trends Shaping the Smart Pills Industry
AI-enabled diagnostics and predictive healthcare
The integration of artificial intelligence into smart pill data analysis is accelerating technology advancement, enabling faster detection of gastrointestinal conditions, predictive disease-risk modeling, and more personalized treatment decisions from ingestible-sensor data.
Regulatory approvals and clinical validation
Ongoing regulatory approvals for new capsule-based diagnostic and drug-delivery products are shaping the regulatory landscape, supporting broader clinical adoption even as high development costs and approval complexity continue to restrain smaller entrants.
Remote patient monitoring and connected health devices
Growing use of ingestible sensors paired with connected healthcare platforms is reshaping the competitive landscape, enabling continuous, real-time patient monitoring that supports the aging and chronically ill population outlined in the market outlook.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/smart-pills-market
Market Segmentation: Breaking Down the Smart Pills Market
Polaris segments the Smart Pills market by application, target area, end use, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.
By Application
The Capsule Endoscopy segment held the largest share, at 46.3% in 2025, driven by the rising global incidence of gastrointestinal disorders such as colon cancer, Crohn's disease, and ulcerative colitis, alongside growing preference for non-invasive diagnostic procedures over traditional endoscopy.
By Target Area
The Small Intestine segment held the largest market share, at 44.1% in 2025, as the increasing prevalence of small-intestine disorders, including Crohn's disease and celiac disease, continues to bolster demand for targeted ingestible-sensor diagnostics.
By End-User
The Hospitals segment is expected to record the fastest growth, at a CAGR of 19.8% through 2034, supported by the availability of advanced diagnostic technologies, specialized healthcare professionals, and comprehensive treatment facilities.
By Region
North America leads global consumption on the strength of advanced diagnostic infrastructure, while Asia Pacific is capturing a rapidly growing share as healthcare investment expands, signaling where near-term demand around “market forecast 2034” is shifting fastest.
Regional Outlook: Where Is Smart Pills Growing Fastest?
North America led the market in 2025 with a 40.7% share, driven by rapid technological advancement in healthcare, high adoption of minimally invasive diagnostics, and a rising prevalence of colorectal cancer and gastrointestinal disorders, while Asia Pacific is projected to register the highest CAGR through 2034, at 20.6%, fueled by expanding healthcare infrastructure and a surging prevalence of stomach cancer and gastrointestinal disease. Within North America, the United States remains the largest single market; within Asia Pacific, Japan, Mongolia, and China are key growth engines given their elevated gastric-cancer incidence rates.
Competitive Landscape: Leading Smart Pills Companies
Key players profiled in the report include CapsoVision, Inc., Medisafe, Medtronic, Olympus Corporation, and Otsuka Holdings Co., Ltd., who are focusing on device enhancement, promotional initiatives, and technological advancement to strengthen market position across the Capsule Endoscopy and Hospitals segments outlined above. A notable recent move includes Centor's April 2025 launch of a smart pill organizer using LTE connectivity for real-time medication-adherence monitoring, enabling pharmacies to offer remote care without requiring patient app setup, deepening share in the connected-health adjacency.
Why It Matters for Buyers Evaluating Market Entry
For stakeholders researching top companies and market forecast in digital diagnostics, this report benchmarks Smart Pills market share, segment-level pricing, and forecast data — by application, target area, end use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing device suppliers, investors sizing entry points, and strategy teams tracking AI-enabled ingestible sensors as a growth adjacency.
About Polaris Market Research
Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.
More Trending Latest Reports By Polaris Market Research:
Integrated Bridge Systems Market